Research suggests that Ganoderma lucidum (reishi mushroom) may have anti-inflammatory properties, with available studies pointing in a supportive direction across several experimental contexts. The evidence base currently consists of an animal study using a nanogel formulation that observed reductions in multiple inflammatory markers in a rat model of rheumatoid arthritis, an in vitro study examining how reishi extracts interact with gut microbiota and immune cells to suppress inflammatory signaling, and a single case report describing topical use in one individual with a skin condition. While these findings collectively suggest plausible mechanisms by which reishi may modulate inflammation, the research is at an early stage and relies heavily on preclinical and laboratory models rather than controlled human trials, which substantially limits the conclusions that can be drawn. The case report in particular cannot establish causation, and none of the studies provide sufficient evidence to determine how these findings would translate to anti-inflammatory effects in humans under real-world conditions.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Lingzhi or Reishi Medicinal Mushroom Ganoderma lucidum (Agaricomycetes) Nanog... | Other | 2024 | Supports | 100 |
| Resolution of Cutaneous Sarcoidosis Following Topical Application of Ganoderm... | Other | 2016 | Supports | 95 |
| Comprehensive evaluation of Ganoderma lucidum extracts: digestion kinetics, g... | Other | 2026 | Supports | 90 |